Blue Cross wins telemedicine grant

Article

Blue Cross wins telemedicine grantBlue Cross of California has received an award of $1.8 million to initiate a telemedicine program for rural communities in California. The Managed Risk Medical Insurance Board (MRMIB) made the grant as part of

Blue Cross wins telemedicine grant

Blue Cross of California has received an award of $1.8 million to initiate a telemedicine program for rural communities in California. The Managed Risk Medical Insurance Board (MRMIB) made the grant as part of the Healthy Families Program, a state-supported insurance program that provides low-cost health, dental, and vision coverage for children of low-income working families. MRMIB established the Rural Health Demonstration Awards in an effort to give rural communities access to health and specialty care.

The grant is expected to fund about 20 new telemedicine sites statewide, as well as extend the company's telemedicine capabilties in roughly 15 others. Blue Cross will take advantage of the already-established telemedicine infrastructure at The University of California, Davis, as it expands its telemedicine base in northern California. Part of the grant funds will be used to develop Blue Cross' telemedicine capabilities at 15 sites in the Northern Sierra Rural Health Network, and the company will work with Cedars Sinai Medical Center as it initiates sites in southern California.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.